Glenside, PA, United States of America

Scott T Harrison

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 10.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Etkins Park, PA (US) (2013)
  • Glenside, PA (US) (2015 - 2016)
  • Elkins Park, PA (US) (2021 - 2024)

Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: Scott T. Harrison: Innovator in Neurological Treatments

Introduction

Scott T. Harrison, an accomplished inventor based in Glenside, Pennsylvania, has made significant contributions to the field of pharmaceutical sciences. With a remarkable portfolio of 11 patents, he has dedicated his career to the development of innovative compounds aimed at addressing neurological and psychiatric disorders.

Latest Patents

Among his notable recent inventions are the compounds titled "3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor." This invention focuses on cinnolinyl and quinolinyl pyrazol-4-yl-pyridine compounds, which exhibit the potential to modulate the M4 muscarinic acetylcholine receptor. Harrison's inventive work is directed toward utilizing these compounds for the treatment or prevention of various neurological and psychiatric conditions associated with these receptors. Additionally, he has developed compositions comprising these innovative compounds, further expanding the potential applications for treating related diseases.

Career Highlights

Scott T. Harrison has had an impressive career, working with reputable organizations such as Merck Sharp & Dohme Corporation and MSD R&D (China) Co., Ltd. His experience with these companies has equipped him with the knowledge and skills necessary to pioneer advancements in pharmaceutical research and development.

Collaborations

Throughout his career, Harrison has collaborated with esteemed colleagues, including Scott E. Wolkenberg and James C. Barrow. These partnerships have fostered an environment of creativity and innovation, allowing for the successful development of groundbreaking therapeutic solutions.

Conclusion

Scott T. Harrison’s contributions to the field of pharmaceuticals, particularly in the development of allosteric modulators for neurological treatment, are commendable. With a strong patent portfolio and notable industry collaborations, he continues to be a vital figure in addressing some of the most challenging health issues of our time.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…